BR9503537A - Composição farmacêutica para administração tópica a um hospedeiro e uso do composto 2-(6-ciano-3, 4-di-hidro-2,2- dimetil-2h-1-benzopiran-4-il) piridina-1-óxido - Google Patents

Composição farmacêutica para administração tópica a um hospedeiro e uso do composto 2-(6-ciano-3, 4-di-hidro-2,2- dimetil-2h-1-benzopiran-4-il) piridina-1-óxido

Info

Publication number
BR9503537A
BR9503537A BR9503537A BR9503537A BR9503537A BR 9503537 A BR9503537 A BR 9503537A BR 9503537 A BR9503537 A BR 9503537A BR 9503537 A BR9503537 A BR 9503537A BR 9503537 A BR9503537 A BR 9503537A
Authority
BR
Brazil
Prior art keywords
benzopyran
dihydro
cyano
pyridine
dimethyl
Prior art date
Application number
BR9503537A
Other languages
English (en)
Inventor
Charles Stanford Harmon
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9503537A publication Critical patent/BR9503537A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9503537A 1994-08-04 1995-08-03 Composição farmacêutica para administração tópica a um hospedeiro e uso do composto 2-(6-ciano-3, 4-di-hidro-2,2- dimetil-2h-1-benzopiran-4-il) piridina-1-óxido BR9503537A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/286,152 US5470861A (en) 1994-08-04 1994-08-04 Method of promoting hair growth

Publications (1)

Publication Number Publication Date
BR9503537A true BR9503537A (pt) 1996-06-04

Family

ID=23097319

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9503537A BR9503537A (pt) 1994-08-04 1995-08-03 Composição farmacêutica para administração tópica a um hospedeiro e uso do composto 2-(6-ciano-3, 4-di-hidro-2,2- dimetil-2h-1-benzopiran-4-il) piridina-1-óxido

Country Status (9)

Country Link
US (1) US5470861A (pt)
EP (1) EP0699429A3 (pt)
JP (1) JP2815325B2 (pt)
CN (1) CN1119529A (pt)
AU (1) AU696300B2 (pt)
BR (1) BR9503537A (pt)
CA (1) CA2155143A1 (pt)
FI (1) FI953709A (pt)
TR (1) TR199500953A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679378A (en) * 1995-12-18 1997-10-21 Olim Industries Of Israel, North America, Ltd. Method and material for hair therapy
US5855877A (en) * 1996-09-06 1999-01-05 Colgate-Palmolive Company Non-aqueous antiperspirant composition
WO1999001453A1 (en) * 1997-07-02 1999-01-14 F. Hoffmann-La Roche Ag A process for the manufacture of optically active chromanylpyridine derivatives
SK12772003A3 (sk) * 2001-04-18 2004-07-07 Prometic Biosciences Inc. Stredne dlhé mastné kyseliny, glyceridy a analógy ako faktory prežitia a aktivácie neutrofilov
US7763587B2 (en) * 2002-06-13 2010-07-27 L'oreal S.A. Derivative of glucose and of vitamin F, compositions comprising it, uses and preparation process
JP5390070B2 (ja) * 2003-02-07 2014-01-15 プロメティック、バイオサイエンシーズ、インコーポレーテッド 赤血球形成刺激薬としての中鎖脂肪酸、グリセリド、および類似体
ES2380940T3 (es) 2004-06-28 2012-05-21 Dsm Ip Assets B.V. Composiciones cosméticas que contienen hidrolizados de proteína
US20060177403A1 (en) * 2005-02-08 2006-08-10 L'oreal Cosmetic/dermatological compositions comprising a derivative of glucose and of vitamin F and A specific surfactant
KR101286782B1 (ko) 2005-09-20 2013-07-17 디에스엠 아이피 어셋츠 비.브이. 신규 카복실산 유도체
FR2902326B1 (fr) * 2006-06-20 2008-12-05 Oreal Utilisation de la coumarine, de butylated hydroxyanisole et d'ethoxyquine pour le traitement de la canitie
WO2012006546A2 (en) * 2010-07-08 2012-01-12 The Johns Hopkins University Circuits, devices and sensors for fluid detection
WO2014152086A1 (en) * 2013-03-19 2014-09-25 The Procter & Gamble Company Method of measuring the metabolic indicators of hair follicles
KR20190081232A (ko) 2017-12-29 2019-07-09 토탈바이오 주식회사 곤충(귀뚜라미)의 단백질과 산야초 추출물의 혼합물를 피부 미백, 세포재생, 보습 유효성분으로 포함하는 화장품 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0187854A4 (en) * 1984-07-13 1987-01-22 Gail S Bazzano SUBSTITUTED PYRIMIDINE OXIDES USEFUL FOR PROMOTING HAIR GROWTH.
AU7875487A (en) * 1986-08-08 1988-02-24 Upjohn Company, The Methods, compositions and solutions for treating alopecia
FR2615191B1 (fr) * 1987-05-16 1991-01-11 Sandoz Sa Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
DE3823533A1 (de) * 1988-07-12 1990-02-08 Beiersdorf Ag Substituierte 4-heterocyclyl-2h-benzo(b)pyrane, verfahren und 4-hydroxy-3-brom-, 3,4-oxiranyl-3,4-dehydro-2h-benzo(b)pyrane als zwischenprodukte zu ihrer herstellung, sowie sie enthaltende pharmazeutsche praeparate
DE3918041A1 (de) * 1989-06-02 1990-12-06 Merck Patent Gmbh Chromanderivate
DE3922392A1 (de) * 1989-07-07 1991-01-17 Merck Patent Gmbh Chromanderivate
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
DE3926001A1 (de) * 1989-08-05 1991-02-07 Merck Patent Gmbh Chromanderivate
FR2657872B2 (fr) * 1989-11-06 1992-06-12 Sanofi Sa Derive d'amidino-4 chromanne, procede d'obtention et compositions pharmaceutiques le contenant.
JP3255411B2 (ja) * 1991-02-18 2002-02-12 中外製薬株式会社 発毛促進剤
JP3020741B2 (ja) * 1992-07-28 2000-03-15 古河機械金属株式会社 海底穿孔装置の砂カバー機構

Also Published As

Publication number Publication date
EP0699429A3 (en) 1999-01-13
FI953709A0 (fi) 1995-08-03
AU2722195A (en) 1996-02-15
TR199500953A1 (tr) 1996-10-21
US5470861A (en) 1995-11-28
JP2815325B2 (ja) 1998-10-27
CA2155143A1 (en) 1996-02-05
CN1119529A (zh) 1996-04-03
EP0699429A2 (en) 1996-03-06
JPH0859442A (ja) 1996-03-05
FI953709A (fi) 1996-02-05
AU696300B2 (en) 1998-09-03

Similar Documents

Publication Publication Date Title
BR0008840B1 (pt) derivados de camptotecina, processos para a sua preparaÇço, composiÇço farmacÊutica que os compreende e uso dos mesmos.
BR0017030B1 (pt) derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos
BR9501770A (pt) Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
BR9607862A (pt) Composição farmacêutica filmogênica para administração transdérmica
MX9101175A (es) Composicion farmaceutica para administracion nasal
BR1100323A (pt) Composto, uso de um composto, composição farmacêutica e processo para preparar um composto
BR9503537A (pt) Composição farmacêutica para administração tópica a um hospedeiro e uso do composto 2-(6-ciano-3, 4-di-hidro-2,2- dimetil-2h-1-benzopiran-4-il) piridina-1-óxido
BR9909995B1 (pt) composto, processo para a preparação de um composto, formulação farmacêutica, e, uso de um composto.
BR9201657A (pt) Compostos derivados aromaticos aminados,processo para a preparacao dos mesmos e composicao farmaceutica
BR9609467A (pt) Composto uso de um composto composição farmacéutica e processos para preparação de um composto e tratamento de distúrbios de agregação planquetária
BR9808422B1 (pt) composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
EE04151B1 (et) Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena
BR9505107A (pt) Composto composiçao farmacêutica processo para a preparaçao de um composto e seu uso
BR9404809A (pt) Composto, uso, formulação farmacêutica e processo para preparar um composto
BR9202522A (pt) Composto,formulacao farmaceutica e processo para preparar um composto
BR9708706B1 (pt) composiÇço farmacÊutica para administraÇço intravenosa a um paciente
BR9004852A (pt) Composto,processo para sua preparacao,sua aplicacao e composicao farmaceutica
BR9711311B1 (pt) derivado de 1,2,3,4-tetrahidroquinolina, composiÇço farmaceutica, uso de um derivado de 1,2,3,4-tetrahidroquinolina, e, processo para a preparaÇço de compostos.
BR9301342A (pt) Composto,formulacao e composicao farmaceutica,processo para preparar um composto
EE200300371A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kopmositsioonid
BR8907107A (pt) Compostos anti-inflamatorios e analgesicos,composicoes relacionadas e metodos para a preparacao e o uso dos mesmos
BR9506106A (pt) Composto processo para sua preparação medicamento e composição farmacêutica
BR9701085A (pt) Derivado de vitamina d cristalina processo para preparar o mesmo medicamento composição farmacéutica processo para preparar a mesma e uso do derivado
BR9807682B1 (pt) composto, uso do mesmo, composiÇço farmacÊutica, e, processos para preparar um composto.
BR9600339A (pt) Compostos composições farmacêuticas processo para a preparação de um composto e uso dos mesmos

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FA8 Dismissal: dismissal - article 36, par. 1 of industrial property law
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/4433 (2006.01), A61K 8/49 (2006.0